Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
NCT00263315
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
320
Enrollment
OTHER
Sponsor class
Conditions
Aspergillosis
Interventions
DRUG:
nebulised liposomal amphotericin B
Sponsor
Erasmus Medical Center
Collaborators
[object Object]
[object Object]